This inventor holds 9 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: University of Michigan, The Brigham and Women's Hospital, Inc.. Active years: 2010-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
9 out of 3,536 
7 out of 1,428 
Years Active: 2010-2019
Title: Rohit Mehra: Innovator in Prostate Cancer Research
Introduction
Rohit Mehra is a prominent inventor based in Ann Arbor, MI, known for his significant contributions to the field of prostate cancer research. With a total of nine patents to his name, he has made remarkable strides in understanding and diagnosing this prevalent disease.
Latest Patents
Among his latest patents, Mehra has focused on recurrent gene fusions in prostate cancer. His work describes the recurrent gene fusions of androgen-regulated genes and ETS family member genes in prostate cancer. Additionally, he has developed compositions and methods that have utility in prostate cancer diagnosis, research, and therapy.
Career Highlights
Mehra has had a distinguished career, working with esteemed institutions such as the University of Michigan and Brigham and Women's Hospital. His research has been pivotal in advancing the understanding of genetic factors in prostate cancer.
Collaborations
Throughout his career, Mehra has collaborated with notable colleagues, including Arul M. Chinnaiyan and Scott Tomlins. These partnerships have further enriched his research and contributed to the field of oncology.
Conclusion
Rohit Mehra's innovative work in prostate cancer research has led to significant advancements in diagnosis and treatment. His contributions continue to impact the medical community and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile